PuSH - Publikationsserver des Helmholtz Zentrums München

Berndt, J. ; Gaumert, R. ; Still, J.S.

Mode of action of the lipid-lowering agents, elofibrate and BM 15075, on cholesterol biosynthesis in rat liver.

Atherosclerosis 30, 147-152 (1978)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
When rats were fed a diet containing 0.3% clofibrate or a derivative of this drug, BM 15075, serum cholesterol was lowered within 3-7 days by 26-38%. Both drugs diminished the activity of hydroxymethylglutaryl CoA reductase, the regulatory enzyme of hepatic cholesterol biosynthesis, in rat liver microsomes by about 60% under the same conditions. The decrease in the activity of the enzyme obviously is due to changes in the amount of enzyme protein. Under in vitro conditions, microsomal hydroxymethylglutaryl CoA reductase was inhibited competitively by (1.35 mM) clofibrate acid (sodium salt) and by BM 15075 (1 mM) with respect to its substrate. These results give evidence that these drugs can affect both, the rate of synthesis and the substrate affinity of hydroxymethylglutaryl CoA reductase.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
ISSN (print) / ISBN 0021-9150
e-ISSN 1879-1484
Zeitschrift Atherosclerosis
Quellenangaben Band: 30, Heft: 2, Seiten: 147-152 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Amsterdam
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institut für Biochemie